Pictet Asset Management
DYN icon

Pictet Asset Management’s Dyne Therapeutics DYN Stock Holding History

Pictet Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Hold
19,372
– – ﹤0.01% 1599
2026
Q1 		$351K Buy
19,372
+6,409
+49% +$111K ﹤0.01% 1646
2025
Q4 		$254K Buy
+12,963
New +$245K ﹤0.01% 1796
2025
Q1 		– Sell
-323,552
Closed -$7.62M – 2032
2024
Q4 		$7.62M Buy
323,552
+18,847
+6% +$557K 0.01% 731
2024
Q3 		$10.3M Buy
304,705
+9,957
+3% +$396K 0.01% 645
2024
Q2 		$10.4M Buy
+294,748
New +$8.56M 0.01% 616

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pictet Asset Management's DYN Position: Q2 2026 in Review

Pictet Asset Management held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 19,372 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Pictet Asset Management first reported a position in DYN in Q2 2024 and has held it in 6 quarters since. The position peaked at $10.4M in Q2 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Pictet Asset Management held 19,372 shares of Dyne Therapeutics worth $430K as of Q2 2026.
  • Pictet Asset Management left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1599 holding.
  • Pictet Asset Management first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Pictet Asset Management's Dyne Therapeutics position peaked at $10.4M in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.